Medtronic Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers Post author:Sam Post published:February 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like PE Firms Take Out New York's AMRI for $922 Million Cash June 5, 2017 Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017 KSQ Emerges With $76 Million and Will be Helmed by Former CEO October 1, 2017
Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017